BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35622005)

  • 21. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification.
    Hébert J; Cayuela JM; Daniel MT; Berger R; Sigaux F
    Blood; 1994 Oct; 84(7):2291-6. PubMed ID: 7919348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias.
    Poirel H; Radford-Weiss I; Rack K; Troussard X; Veil A; Valensi F; Picard F; Guesnu M; Leboeuf D; Melle J
    Blood; 1995 Mar; 85(5):1313-22. PubMed ID: 7858261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute myeloid leukaemia (FAB AML-M4Eo) with cryptic insertion of cbfb resulting in cbfb-Myh11 fusion.
    Douet-Guilbert N; Chauveau A; Gueganic N; Guillerm G; Tous C; Le Bris MJ; Basinko A; Morel F; Ugo V; De Braekeleer M
    Hematol Oncol; 2017 Sep; 35(3):385-389. PubMed ID: 28906004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia.
    Dierlamm J; Stul M; Vranckx H; Michaux L; Weghuis DE; Speleman F; Selleslag D; Kramer MH; Noens LA; Cassiman JJ; Van den Berghe H; Hagemeijer A
    Genes Chromosomes Cancer; 1998 Jun; 22(2):87-94. PubMed ID: 9598794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CBFB/MYH11 fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16.
    Pirc-Danoewinata H; Dauwerse HG; König M; Chudoba I; Mitterbauer M; Jäger U; Breuning MH; Haas OA
    Genes Chromosomes Cancer; 2000 Oct; 29(2):186-91. PubMed ID: 10959099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
    Mrózek K; Prior TW; Edwards C; Marcucci G; Carroll AJ; Snyder PJ; Koduru PR; Theil KS; Pettenati MJ; Archer KJ; Caligiuri MA; Vardiman JW; Kolitz JE; Larson RA; Bloomfield CD
    J Clin Oncol; 2001 May; 19(9):2482-92. PubMed ID: 11331327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice.
    Saida S; Zhen T; Kim E; Yu K; Lopez G; McReynolds LJ; Liu PP
    Leukemia; 2020 Mar; 34(3):759-770. PubMed ID: 31624376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis.
    Martinez-Climent JA; Comes AM; Vizcarra E; Reshmi S; Benet I; Marugan I; Tormo M; Terol MJ; Solano C; Arbona C; Prosper F; Barragan E; Bolufer P; Rowley JD; García-Conde J
    Cancer Genet Cytogenet; 1999 Apr; 110(2):111-4. PubMed ID: 10214358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
    Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):. PubMed ID: 35400360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
    Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):367-372. PubMed ID: 35395965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
    Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
    Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature.
    Fujieda A; Nishii K; Tamaru T; Otsuki S; Kobayashi K; Monma F; Ohishi K; Nakase K; Katayama N; Shiku H
    Leuk Res; 2006 Aug; 30(8):1053-7. PubMed ID: 16504290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.
    Van der Reijden BA; de Wit L; van der Poel S; Luiten EB; Lafage-Pochitaloff M; Dastugue N; Gabert J; Löwenberg B; Jansen JH
    Hematol J; 2001; 2(3):206-9. PubMed ID: 11920247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of a new variant of the CBF beta-MYH11 gene fusion.
    Stulberg J; Kamel-Reid S; Chun K; Tokunaga J; Wells RA
    Leuk Lymphoma; 2002 Oct; 43(10):2021-6. PubMed ID: 12481902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotype.
    Haferlach C; Alpermann T; Schnittger S; Kern W; Chromik J; Schmid C; Pielken HJ; Kreuzer KA; Höffkes HG; Haferlach T
    Blood; 2012 Mar; 119(9):2122-5. PubMed ID: 22207733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council.
    Langabeer SE; Grimwade D; Walker H; Rogers JR; Burnett AK; Goldstone AH; Linch DC
    Br J Haematol; 1998 May; 101(2):338-40. PubMed ID: 9609531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute myeloid leukemia with cryptic CBFB-MYH11 type D.
    Kobayashi T; Ichikawa M; Kamikubo Y; Kurokawa M
    Int J Clin Exp Pathol; 2013; 6(1):110-2. PubMed ID: 23236551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML.
    Dawson AJ; Bal S; McTavish B; Tomiuk M; Schroedter I; Ahsanuddin AN; Seftel MD; Vallente R; Mai S; Cotter PD; Hovanes K; Gorre M; Gunn SR
    Cancer Genet; 2011 Jun; 204(6):344-7. PubMed ID: 21763633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical aspects of expression of inversion 16 chromosomal fusion transcript CBFB/MYH11 in acute myelogenous leukemia subtype M1 with abnormal bone marrow eosinophilia.
    Monahan BP; Rector JT; Liu PP; Cotelingam JD; Dahut W
    Leukemia; 1996 Oct; 10(10):1653-4. PubMed ID: 8847901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.